![Chemical structure of 2,4-Imidazolidinedione,5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-, CAS 63612-50-0](https://api.angenesci.com/structure/1620/63612-50-0.png)
无数据
无数据
无数据
| CAS Number | 63612-50-0 |
| Catalog Number | AG01CBPK(AGN-PC-0T9AL1) |
| Chemical Name | 2,4-Imidazolidinedione,5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]- |
| IUPAC Name | 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione |
| InChI | InChI=1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20) |
| InChI Key | XWXYUMMDTVBTOU-UHFFFAOYSA-N |
| MDL Number | MFCD00864670 |
| Molecular Formula | C12H10F3N3O4 |
| Molecular Weight | 317.2207 |
| NSC Number | 758683 |
| SMILES | CC1(C(=O)N(C(=O)N1)c2ccc(c(c2)C(F)(F)F)N(=O)=O)C |
| UNII | 51G6I8B902 |
| Synonyms | 5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)- 2,4-imidazolidinedione,
Anandron,
Nilandron,
nilutamide,
RU 23908,
RU 23908-10,
RU-23908,
nilutamide,
63612-50-0,
Anandron,
Nilandron,
Nilandrone,
Nilutamida,
Nilutamidum,
5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione,
Nilutamidum [Latin],
Nilutamida [Spanish],
RU-23908,
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione,
Nilutamide [USAN:INN:BAN],
RU 23908,
RU 23908-10,
UNII-51G6I8B902,
5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin,
C12H10F3N3O4,
BRN 0841906,
CHEMBL1274,
CHEBI:7573,
XWXYUMMDTVBTOU-UHFFFAOYSA-N,
1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione,
5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)-2,4-imidazolidinedione,
5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione,
MFCD00864670,
51G6I8B902,
NCGC00015754-08,
CAS-63612-50-0,
2,4-IMIDAZOLIDINEDIONE, 5,5-DIMETHYL-3-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)-,
DSSTox_CID_14165,
DSSTox_RID_79118,
DSSTox_GSID_34165,
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-1,3-diazolidine-2,4-dione,
Nilandron (TN),
Nilutamide [USAN:BAN:INN],
SR-01000076034,
Nilutamide (USAN/INN),
Nilutamide, solid,
PubChem19359,
Spectrum_001625,
Tocris-1759,
SpecPlus_000902,
AC1L1IAG,
Prestwick0_000928,
Prestwick1_000928,
Prestwick2_000928,
Prestwick3_000928,
Spectrum2_001973,
Spectrum3_001633,
Spectrum4_000600,
Spectrum5_001512,
Lopac-N-8534,
N 8534,
BIDD:PXR0177,
Lopac0_000879,
SCHEMBL12670,
BSPBio_000836,
BSPBio_003325,
KBioGR_001100,
KBioSS_002105,
MLS002154066,
BIDD:GT0683,
DivK1c_006998,
SPECTRUM1504152,
SPBio_002125,
SPBio_003015,
BPBio1_000920,
GTPL2864,
DTXSID3034165,
CTK8B7740,
KBio1_001942,
KBio2_002105,
KBio2_004673,
KBio2_007241,
KBio3_002545,
BCPP000148,
HMS1570J18,
HMS1922F03,
HMS2093A10,
HMS2097J18,
HMS2230E03,
HMS3262P19,
HMS3268C18,
HMS3369I02,
HMS3678N13,
HMS3714J18,
Pharmakon1600-01504152,
BCP26617,
ZINC3874498,
Tox21 110213,
Tox21_110213,
Tox21_301589,
Tox21_500879,
ANW-58327,
BDBM50135912,
CCG-39427,
NSC758683,
SBB067297,
STK633161,
5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)- 2,4-imidazolidinedione,
AKOS005565152,
AKOS025147305,
Tox21_110213_1,
AC-5260,
BCP9000990,
DB00665,
LP00879,
MCULE-3215206804,
NSC-758683,
RU23908,
SB19036,
NCGC00015754-01,
NCGC00015754-02,
NCGC00015754-03,
NCGC00015754-04,
NCGC00015754-05,
NCGC00015754-06,
NCGC00015754-07,
NCGC00015754-09,
NCGC00015754-10,
NCGC00015754-11,
NCGC00015754-12,
NCGC00015754-15,
NCGC00015754-16,
NCGC00025280-01,
NCGC00025280-02,
NCGC00025280-03,
NCGC00025280-04,
NCGC00025280-05,
NCGC00025280-06,
NCGC00025280-07,
NCGC00025280-08,
NCGC00255271-01,
NCGC00261564-01,
4CA-0906,
AJ-46401,
AK-82300,
AN-11150,
AS-14123,
K002,
LS-79181,
SC-74493,
SMR001233381,
ST075550,
SBI-0050854.P003,
AB0013969,
TC-030602,
AB00053180,
EU-0100879,
FT-0080574,
FT-0630740,
C08164,
D00965,
AB00053180_07,
612N500,
A834440,
L000759,
I14-2740,
SR-01000076034-1,
SR-01000076034-3,
SR-01000076034-5,
SR-01000076034-6,
SR-01000076034-9,
BRD-K23566484-001-05-2,
BRD-K23566484-001-09-4,
Z2417927201,
Nilutamide, European Pharmacopoeia (EP) Reference Standard,
1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione,
1-(3'-trifluoromethyl-4'-nitrophenyl)4,4-dimethyl-imidazoline-2,5-dione,
1-(3'-trifluoromethyl-4'nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione,
1-(3'trifluoromethyl-4'-nitropheyl)-4,4-dimethyl-imidazoline-2,5-dione,
1-(3-'trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione,
1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl imidazolidine-2,5-dione,
1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazolidine-2,5-dione,
1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazoline-2,5-dione,
1-(3-trifluoromethyl-4-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione,
3-(3-(trifluoromethyl)-4-nitrophenyl)-5,5-dimethylimidazolidine-2,4-dione,
5,5-Dimethyl-3-(4-nitro-3-trifluoromethyl-phenyl)-imidazolidine-2,4-dione,
2,4-Imidazolidinedione,5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-,
5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)-phenyl)imidazolidine-2,4-dione,
5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-imidazolidine-2,4-dione,
Anandron (TN),
D0SN9T,
Aventis Brand of Nilutamide,
Hoechst Brand of Nilutamide,
CID4493,
Aventis Behring Brand of Nilutamide,
C12-H10-F3-N3-O4,
CS-O-30698,
5-24-05-00358 (Beilstein Handbook Reference),
C021277,
|
| Complexity | 515 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 317.062g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 22 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 317.224g/mol |
| Monoisotopic Mass | 317.062g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 95.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

